

Cis-Atrabloc 10 Injection
Manufacturer
Varenyam Healthcare Pvt Ltd
Salt Composition
Cisatracurium (2mg)
Key Information
Short Description
Cis-Atrabloc 10 Injection is a muscle relaxant used to provide skeletal muscle relaxation during surgical procedures and facilitate emergency airway management in patients in intensive care.
Dosage Form
Injection
Introduction
Cis-Atrabloc 10 Injection is generally administered by a healthcare professional. You should not self-administer this medicine at home. The dose and duration will depend on what you are taking it for and how well it helps your symptoms. The most common side effects of this medicine include slow heart rate, decreased blood pressure, and injection site reactions such as pain, redness, and swelling. If any of these side effects do not resolve with time or get worse, you should let your doctor know. Your doctor may be able to suggest ways of preventing or reducing the symptoms. Before using it, you should let your doctor know if you have any medical conditions or disorders. You should also tell your doctor all the other medicines you are using or taking. Pregnant and breastfeeding women should consult their doctors before using this medicine.
Directions for Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety Information
Side Effects
slow heart rate decreased blood pressure injection site reactions such as pain, redness, and swelling
Alcohol Warning
It is not known whether it is safe to consume alcohol with Cis-Atrabloc 10 Injection. Please consult your doctor.
Breastfeeding Warning
Cis-Atrabloc 10 Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy Warning
Cis-Atrabloc 10 Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Interacting Medicines
antibiotics antihypertensives medicines for fits medicines for joint inflammation
How it works
Cis-Atrabloc 10 Injection relaxes the muscles by blocking the impulses from the nerves.
Quick Tips
Cis-Atrabloc 10 Injection is administered to relax muscles during surgery Inform your doctor if you have muscle weakness, tiredness, or difficulty in coordinating your movements Inform your doctor if you have ever had an allergic reaction to any muscle relaxant which was given as part of an operation Give complete details if you are taking any other medications like antibiotics, antihypertensives, medicines for fits, and medicines for joint inflammation
Frequently asked questions
What is the purpose of administering Cis-Atrabloc 10 Injection?
Cis-Atrabloc 10 Injection is utilized to relax muscles before undergoing general anesthesia during surgery.
How is Cis-Atrabloc 10 Injection administered?
This medication can be given as a single injection directly into the vein or as a continuous infusion, where the medicine is slowly administered over an extended period. The method and dosage will be determined by your doctor, taking into account your body weight, the required duration of muscle relaxation, and expected response to the medication.
What information should I disclose to my doctor before receiving Cis-Atrabloc 10 Injection?
Inform your doctor if you have a known allergy or hypersensitivity to cisatracurium, other muscle relaxants, or previous adverse reactions to anesthetics. This will help ensure your safety and the effective administration of the medication.
What are the consequences of overdosing on Cis-Atrabloc 10 Injection?
Given that Cis-Atrabloc 10 Injection is administered in a controlled medical setting, the likelihood of an overdose occurring is extremely low. However, if you have any concerns or questions, it is best to consult with your doctor.
Can breastfeeding women be given Cis-Atrabloc 10 Injection?
Yes, breastfeeding women can receive Cis-Atrabloc 10 Injection under the guidance of a medical professional. However, they are advised to abstain from breastfeeding for three hours after treatment has been discontinued.